Philip Chambers

497 total citations
11 papers, 282 citations indexed

About

Philip Chambers is a scholar working on Biomedical Engineering, Molecular Biology and Epidemiology. According to data from OpenAlex, Philip Chambers has authored 11 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Biomedical Engineering, 3 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in Philip Chambers's work include Bone Tissue Engineering Materials (5 papers), Graphene and Nanomaterials Applications (4 papers) and Hydrogels: synthesis, properties, applications (2 papers). Philip Chambers is often cited by papers focused on Bone Tissue Engineering Materials (5 papers), Graphene and Nanomaterials Applications (4 papers) and Hydrogels: synthesis, properties, applications (2 papers). Philip Chambers collaborates with scholars based in United Kingdom, Ireland and United States. Philip Chambers's co-authors include Helen O. McCarthy, Nicholas Dunne, Sreekanth Pentlavalli, Andi Dian Permana, Eneko Larrañeta, Ke Peng, Lalitkumar K. Vora, Juan Domínguez‐Robles, Delly Ramadon and Ryan F. Donnelly and has published in prestigious journals such as Journal of Controlled Release, Journal of General Virology and Materials Science and Engineering C.

In The Last Decade

Philip Chambers

11 papers receiving 278 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Chambers United Kingdom 8 105 73 60 53 43 11 282
David Woolfson United Kingdom 10 161 1.5× 197 2.7× 81 1.4× 14 0.3× 80 1.9× 26 579
Corona M. Cassidy United Kingdom 11 127 1.2× 344 4.7× 86 1.4× 23 0.4× 77 1.8× 12 635
Olivia M. Saouaf United States 10 32 0.3× 80 1.1× 95 1.6× 47 0.9× 6 0.1× 17 332
Séverine Munier France 12 138 1.3× 39 0.5× 255 4.3× 13 0.2× 43 1.0× 15 514
Amy S. Determan United States 8 339 3.2× 87 1.2× 201 3.4× 25 0.5× 129 3.0× 9 668
James Jung United States 10 68 0.6× 37 0.5× 164 2.7× 7 0.1× 21 0.5× 16 434
Kjersti Julin Norway 10 80 0.8× 45 0.6× 92 1.5× 35 0.7× 17 0.4× 14 343
Silvia Villullas Spain 10 121 1.2× 88 1.2× 92 1.5× 26 0.5× 36 0.8× 11 649
Jonathan K. Tsosie United States 6 76 0.7× 77 1.1× 422 7.0× 38 0.7× 10 0.2× 8 675
Arthur Vijayan Lal India 8 126 1.2× 31 0.4× 64 1.1× 42 0.8× 5 0.1× 12 405

Countries citing papers authored by Philip Chambers

Since Specialization
Citations

This map shows the geographic impact of Philip Chambers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Chambers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Chambers more than expected).

Fields of papers citing papers by Philip Chambers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Chambers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Chambers. The network helps show where Philip Chambers may publish in the future.

Co-authorship network of co-authors of Philip Chambers

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Chambers. A scholar is included among the top collaborators of Philip Chambers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Chambers. Philip Chambers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
McCrudden, Cian M., Philip Chambers, Sarah Kuhn, et al.. (2023). Peptide delivery of a multivalent mRNA SARS-CoV-2 vaccine. Journal of Controlled Release. 362. 536–547. 13 indexed citations
2.
Peng, Ke, Lalitkumar K. Vora, Ismaiel A. Tekko, et al.. (2021). Dissolving microneedle patches loaded with amphotericin B microparticles for localised and sustained intradermal delivery: Potential for enhanced treatment of cutaneous fungal infections. Journal of Controlled Release. 339. 361–380. 105 indexed citations
3.
Mulholland, Eoghan J., Philip Chambers, Sreekanth Pentlavalli, et al.. (2020). Improving the Intercellular Uptake and Osteogenic Potency of Calcium Phosphate via Nanocomplexation with the RALA Peptide. Nanomaterials. 10(12). 2442–2442. 7 indexed citations
4.
Chambers, Philip, et al.. (2019). Nanocomposite-coated porous templates for engineered bone scaffolds: a parametric study of layer-by-layer assembly conditions. Biomedical Materials. 14(6). 65008–65008. 13 indexed citations
5.
Pentlavalli, Sreekanth, et al.. (2017). Influence of alginate backbone on efficacy of thermo-responsive alginate-g-P(NIPAAm) hydrogel as a vehicle for sustained and controlled gene delivery. Materials Science and Engineering C. 95. 409–421. 49 indexed citations
6.
Sathy, Binulal N., Dinorath Olvera, Tomas Gonzalez‐Fernandez, et al.. (2017). RALA complexed α-TCP nanoparticle delivery to mesenchymal stem cells induces bone formation in tissue engineered constructs in vitro and in vivo. Journal of Materials Chemistry B. 5(9). 1753–1764. 19 indexed citations
8.
Chambers, Philip, et al.. (2016). Delivery of self-assembling osteogenic nanoparticles via a thermo-responsive nanofibre reinforced hydrogel. Frontiers in Bioengineering and Biotechnology. 4. 2 indexed citations
9.
Pentlavalli, Sreekanth, et al.. (2015). Osteogenic Potential of Self-Assembling Bioceramic Nanoparticles. Research Portal (Queen's University Belfast). 1 indexed citations
10.
Chambers, Philip, B. K. Rima, & W. Paul Duprex. (2009). Molecular differences between two Jeryl Lynn mumps virus vaccine component strains, JL5 and JL2. Journal of General Virology. 90(12). 2973–2981. 18 indexed citations
11.
Taylor, Debra L., Parvin S. Ahmed, A.S. Tyms, et al.. (2000). Drug Resistance and Drug Combination Features of the Human Immunodeficiency Virus Inhibitor, BCH-10652 [(±)-2′-Deoxy-3′-Oxa-4′-Thiocytidine, dOTC]. Antiviral chemistry & chemotherapy. 11(4). 291–301. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026